• Baechler, E.C., Batliwalla, F.M., Karypis, G., Gaffney, P.M., Moser, K., Ortmann, W.A., Espe, K.J., Balasubramanian, S., Hughes, K.M., Chan, J.P., Begovich, A., Chang, S.Y., Gregersen, P.K. & Behrens, T.W. (2004) Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes and Immunity, 5, 347353.
  • Baechler, E.C., Batliwalla, F.M., Reed, A.M., Peterson, E.J., Gaffney, P.M., Moser, K.L., Gregersen, P.K. & Behrens, T.W. (2006) Gene expression profiling in human autoimmunity. Immunological Reviews, 210, 120137.
  • Bennett, L., Palucka, A.K., Arce, E., Cantrell, V., Borvak, J., Banchereau, J. & Pascual, V. (2003) Interferon and granulopoiesis signatures in systemic lupus erythematosus blood. Journal of Experimental Medicine, 197, 711723.
  • Cooper, N. & Bussel, J. (2006) The pathogenesis of immune thrombocytopenic purpura. British Journal Haematology, 133, 364374.
  • Denny, M.F., Chandaroy, P., Killen, P.D., Caricchio, R., Lewis, E.E., Richardson, B.C., Lee, K.D., Gavalchin, J. & Kaplan, M.J. (2006) Accelerated macrophage apoptosis induces autoantibody formation and organ damage in systemic lupus erythematosus. Journal of Immunology, 176, 20952104.
  • Emmerich, F., Bal, G., Barakat, A., Milz, J., Muhle, C., Martinez-Gamboa, L., Dorner, T. & Salama, A. (2007) High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura. British Journal of Haematology, 136, 309314.
  • Imbach, P. (2006) Development and research in idiopathic thrombocytopenic purpura: an inflammatory and autoimmune disorder. Pediatric Blood Cancer, 47, 685686.
  • Kirou, K.A., Lee, C., George, S., Louca, K., Papagiannis, I.G., Peterson, M.G., Ly, N., Woodward, R.N., Fry, K.E., Lau, A.Y., Prentice, J.G., Wohlgemuth, J.G. & Crow, M.K. (2004) Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus. Arthritis and Rheumatism, 50, 39583967.
  • Kirou, K.A., Lee, C., George, S., Louca, K., Peterson, M.G. & Crow, M.K. (2005) Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease. Arthritis and Rheumatism, 52, 14911503.
  • Olsson, B., Andersson, P.O., Jernas, M., Jacobsson, S., Carlsson, B., Carlsson, L.M. & Wadenvik, H. (2003) T-cell-mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura. Nature Medicine, 9, 11231124.
  • Sood, R., Wong, W., Jeng, M. & Zehnder, J.L. (2006) Gene expression profile of idiopathic thrombocytopenic purpura (ITP). Pediatric Blood Cancer, 47(Suppl. 5), 675677.
  • Tan, F.K., Zhou, X., Mayes, M.D., Gourh, P., Guo, X., Marcum, C., Jin, L. & Arnett, Jr, F.C. (2006) Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients. Rheumatology (Oxford), 45, 694702.
  • Tusher, V.G., Tibshirani, R. & Chu, G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America, 98, 51165121.
  • Viorritto, I.C., Nikolov, N.P. & Siegel, R.M. (2007) Autoimmunity versus tolerance: can dying cells tip the balance? Clinical Immunology, 122, 125134.
  • Zhang, X.K., Gallant, S., Molano, I., Moussa, O.M., Ruiz, P., Spyropoulos, D.D., Watson, D.K. & Gilkeson, G. (2004) Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. Journal of Immunology, 173, 64816489.